Astrotech Corporation (DE) Common Stock vs. 10x Genomics, Inc. Class A Common Stock
ASTC
Astrotech Corporation (DE) Common Stock
$6.13 -0.97%
VS TXG10x Genomics, Inc. Class A Common Stock
$79.10 +3.26%
10x Genomics, Inc. Class A Common Stock (TXG) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| ASTC | TXG | |
|---|---|---|
| Market Cap | $12.92 million | $9.98 billion |
| Revenue (TTM) | $958,000 | $616.91 million |
| Net Income (TTM) | $-14,090,000 | $-75,125,000 |
TXG leads on 2 of 3 size & scale factors.
Valuation
| ASTC | TXG | |
|---|---|---|
| Price / Book | 1.06 | 12.09 |
| Price / Sales | 13.49 | 16.18 |
ASTC leads on 2 of 2 valuation factors.
Profitability
| ASTC | TXG | |
|---|---|---|
| Net Margin | -1470.77% | -12.18% |
| Return on Equity | -115.92% | -9.10% |
TXG leads on 2 of 2 profitability factors.
Risk & Sentiment
| ASTC | TXG | |
|---|---|---|
| Short Interest | 1.46% | 0.42% |
TXG leads on 1 of 1 risk & sentiment factors.
Dig deeper: ASTC overview, ASTC financials, TXG overview, TXG financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.